These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24352914)

  • 1. Anxiety, attention problems, hyperactivity, and the Aberrant Behavior Checklist in fragile X syndrome.
    Wheeler A; Raspa M; Bann C; Bishop E; Hessl D; Sacco P; Bailey DB
    Am J Med Genet A; 2014 Jan; 164A(1):141-55. PubMed ID: 24352914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index.
    Raspa M; Sacco P; Candrilli SD; Bishop E; Petrillo J
    J Intellect Disabil Res; 2016 Sep; 60(9):844-55. PubMed ID: 26929037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health and economic consequences of fragile X syndrome for caregivers.
    Bailey DB; Raspa M; Bishop E; Mitra D; Martin S; Wheeler A; Sacco P
    J Dev Behav Pediatr; 2012; 33(9):705-12. PubMed ID: 23117595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey.
    Bailey DB; Raspa M; Bishop E; Olmsted M; Mallya UG; Berry-Kravis E
    J Dev Behav Pediatr; 2012 Jan; 33(1):62-9. PubMed ID: 22064563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor Structure of the Aberrant Behavior Checklist in Individuals with Fragile X Syndrome: Clarifications and Future Guidance.
    Aman MG; Norris M; Kaat AJ; Andrews H; Choo TH; Chen C; Wheeler A; Bann C; Erickson C
    J Child Adolesc Psychopharmacol; 2020 Oct; 30(8):512-521. PubMed ID: 32746626
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study.
    Haessler F; Gaese F; Huss M; Kretschmar C; Brinkman M; Peters H; Elstner S; Colla M; Pittrow D
    BMC Psychiatry; 2016 Sep; 16(1):318. PubMed ID: 27612457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal trajectories of aberrant behavior in fragile X syndrome.
    Hustyi KM; Hall SS; Jo B; Lightbody AA; Reiss AL
    Res Dev Disabil; 2014 Nov; 35(11):2691-701. PubMed ID: 25129200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatment.
    Sansone SM; Widaman KF; Hall SS; Reiss AL; Lightbody A; Kaufmann WE; Berry-Kravis E; Lachiewicz A; Brown EC; Hessl D
    J Autism Dev Disord; 2012 Jul; 42(7):1377-92. PubMed ID: 21972117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autism and anxiety in males with fragile X syndrome: an exploratory analysis of neurobehavioral profiles from a parent survey.
    Talisa VB; Boyle L; Crafa D; Kaufmann WE
    Am J Med Genet A; 2014 May; 164A(5):1198-203. PubMed ID: 24664669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aberrant behavior profile in Indonesian individuals with fragile X syndrome with limited genetic services.
    Winarni TI; Sumekar TA; Sarjana W; Hardian H; Hagerman RJ; Faradz SM
    Intractable Rare Dis Res; 2022 Nov; 11(4):215-218. PubMed ID: 36457587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability.
    Ouyang L; Grosse SD; Riley C; Bolen J; Bishop E; Raspa M; Bailey DB
    Res Dev Disabil; 2014 Jul; 35(7):1518-27. PubMed ID: 24755230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telehealth-enabled behavioral treatment for problem behaviors in boys with fragile X syndrome: a randomized controlled trial.
    Hall SS; Monlux KD; Rodriguez AB; Jo B; Pollard JS
    J Neurodev Disord; 2020 Nov; 12(1):31. PubMed ID: 33218305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.
    Heussler H; Cohen J; Silove N; Tich N; Bonn-Miller MO; Du W; O'Neill C; Sebree T
    J Neurodev Disord; 2019 Aug; 11(1):16. PubMed ID: 31370779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination disorders in persons with Prader-Willi and Fragile-X syndromes.
    Equit M; Piro-Hussong A; Niemczyk J; Curfs L; von Gontard A
    Neurourol Urodyn; 2013 Sep; 32(7):986-92. PubMed ID: 23239431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
    Berry-Kravis E; Sumis A; Hervey C; Nelson M; Porges SW; Weng N; Weiler IJ; Greenough WT
    J Dev Behav Pediatr; 2008 Aug; 29(4):293-302. PubMed ID: 18698192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early temperament and negative reactivity in boys with fragile X syndrome.
    Shanahan M; Roberts J; Hatton D; Reznick J; Goldsmith H
    J Intellect Disabil Res; 2008 Oct; 52(10):842-54. PubMed ID: 18498331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can the behavioural phenotype of fragile X syndrome be attributed to mental retardation and to attention deficit hyperactivity disorder?].
    Artigas-Pallarés J; Brun-Gasca C
    Rev Neurol; 2004 Jan 1-15; 38(1):7-11. PubMed ID: 14730483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety and threat-related attentional biases in adolescents with fragile X syndrome.
    Kelleher BL; Hogan AL; Ezell J; Caravella K; Schmidt J; Wang Q; Roberts JE
    J Intellect Disabil Res; 2020 Apr; 64(4):296-302. PubMed ID: 32020687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label add-on treatment trial of minocycline in fragile X syndrome.
    Paribello C; Tao L; Folino A; Berry-Kravis E; Tranfaglia M; Ethell IM; Ethell DW
    BMC Neurol; 2010 Oct; 10():91. PubMed ID: 20937127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives.
    Lozano R; Thompson T; Dixon-Weber J; Erickson CA; Berry-Kravis E; Williams S; Smith E; Frazier JA; Rosselot H; Farmer C; Hessl D
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.